Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

STAT nuclear translocation: potential for pharmacological intervention.

Thomas Meyer1, Uwe Vinkemeier

  • 1Philipps-Universität Marburg, Klinik für Kardiologie und Klinik für Psychosomatische Medizin und Psychotherapie, Baldingerstrasse 1, 35033 Marburg, Germany. meyert@med.uni-marburg.de

Expert Opinion on Therapeutic Targets
|October 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the epigenome and the integrated stress response to normalize colorectal cancer subclonal plasticity and progression.

Cell death & disease·2026
Same author

Between guidelines and reality: expert neurologists' perspectives on structural resources for ALS care in Germany.

Neurological research and practice·2026
Same author

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2026
Same author

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Annals of hematology·2026
Same author

Nuclear export block of tyrosine-phosphorylated STAT1 facilitates rapid responsiveness to interferon-γ stimuli at the expense of signal strength.

Biochimica et biophysica acta. Gene regulatory mechanisms·2026
Same author

ALS motor phenotypes: a revised 'OPM' classification.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same journal

The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directions.

Expert opinion on therapeutic targets·2026
Same journal

Hepatocyte nuclear factor 4α - prospects for therapeutic targeting.

Expert opinion on therapeutic targets·2026
Same journal

The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances.

Expert opinion on therapeutic targets·2026
Same journal

Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma.

Expert opinion on therapeutic targets·2026
Same journal

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same journal

The AT<sub>2</sub> receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Expert opinion on therapeutic targets·2026
See all related articles

Signal transducer and activator of transcription (STAT) proteins regulate gene expression. Modulating STAT protein transport between the nucleus and cytoplasm offers a therapeutic strategy for diseases linked to aberrant STAT signaling.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Signal transducer and activator of transcription (STAT) proteins are crucial transcription factors mediating diverse biological processes.
  • STAT protein activation involves tyrosine phosphorylation upon stimulation by cytokines or growth factors, leading to gene regulation.
  • Aberrant STAT signaling is implicated in various diseases, including cancer, immune disorders, and inflammatory conditions.

Purpose of the Study:

  • To review the role of STAT protein nucleocytoplasmic translocation in cellular signaling.
  • To explore the potential of targeting STAT shuttling as a therapeutic strategy for STAT-dysregulated diseases.
  • To discuss the implications of modulating STAT activation and transcriptional activity.

Main Methods:

Related Experiment Videos

  • Review of existing literature on STAT protein function, signaling pathways, and intracellular trafficking.
  • Analysis of karyopherin-dependent and -independent translocation mechanisms.
  • Discussion of pharmacological approaches to modulate STAT nucleocytoplasmic transport.

    • Main Results:

    • STAT proteins shuttle continuously between the nucleus and cytoplasm, a process essential for cytokine-regulated gene activation.
    • STAT proteins possess cytokine-independent gene regulatory functions dependent on their nucleocytoplasmic transfer.
    • Targeting STAT nucleocytoplasmic translocation presents a promising strategy to interfere with dysregulated cytokine signaling.

    Conclusions:

    • Modulators of STAT shuttling could offer novel therapeutic interventions for diseases driven by aberrant STAT signaling.
    • Pharmacological targeting of STAT translocation may lead to increased or decreased STAT activation, offering versatile therapeutic potential.
    • Understanding STAT intracellular trafficking is key to developing effective treatments for a range of human diseases.